Position in OGN
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$677
+$676 QoQ
Shares Held
50
-74.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#497
of 626 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CX Institutional holds $115,444,232 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,493 | $42,571,372 | |
| 2 | ABBV |
AbbVie Inc.
|
78,286 | $19,699,889 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
263,596 | $15,188,401 | |
| 4 | MRK |
Merck & Co., Inc.
|
95,317 | $12,248,234 | |
| 5 | AMGN |
Amgen Inc
|
25,985 | $9,409,688 | |
| 6 | JNJ |
Johnson & Johnson
|
30,364 | $7,711,545 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,297 | $7,365,242 | |
| 8 | PFE |
Pfizer Inc
|
27,825 | $670,026 |
All Filings in OGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $677 | 50 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $1 | 192 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $1 | 191 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $4,912 | 460 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $3,775 | 390 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $5,807 | 390 | Shares | Sole | 2025-04-15 | |
| 2022-06-30 | $48,262 | 1,430 | Shares | Sole | 2022-08-02 | |
| 2021-09-30 | $38,069 | 1,161 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $68,750 | 2,272 | Shares | Sole | 2021-08-04 | |
| No filing history on record for this holder in this stock. | ||||||